Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Malignant Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02595866
What this trial is testing

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Who this might be right for
AIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more
National Cancer Institute (NCI) 58
Testing effectiveness (Phase 2)Study completedNCT03765229
What this trial is testing

An Exploratory Study of Pembrolizumab Plus Entinostat in Non-Inflamed Stage III/IV Melanoma

Who this might be right for
Melanoma
UNC Lineberger Comprehensive Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT00003646
What this trial is testing

Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Stage IV MelanomaStage III MelanomaRecurrent Melanoma
Vical 78
Testing effectiveness (Phase 2)Study completedNCT00651703
What this trial is testing

Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients

Who this might be right for
Malignant Melanoma
Cytos Biotechnology AG 21
Testing effectiveness (Phase 2)Study completedNCT00003346
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Memorial Sloan Kettering Cancer Center 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT01989585
What this trial is testing

Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant Melanoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Malignant Solid Neoplasm+2 more
National Cancer Institute (NCI) 75
Large-scale testing (Phase 3)Ended earlyNCT03273153
What this trial is testing

Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma

Who this might be right for
Advanced BRAFV600 Wild-type Melanoma
Hoffmann-La Roche 446
Testing effectiveness (Phase 2)Study completedNCT00004022
What this trial is testing

Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Barbara Ann Karmanos Cancer Institute
Large-scale testing (Phase 3)Study completedNCT00019682
What this trial is testing

Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma

Who this might be right for
Recurrent MelanomaStage IIIA Skin MelanomaStage IIIB Skin Melanoma+2 more
National Cancer Institute (NCI) 185
Testing effectiveness (Phase 2)Study completedNCT00591370
What this trial is testing

Phase II Trial of Extended-Dosing Temozolomide in Patients With Melanoma

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 51
Large-scale testing (Phase 3)Study completedNCT02166788
What this trial is testing

Evaluation of Groin Lymphadenectomy Extent For Metastatic Melanoma

Who this might be right for
Metastatic Melanoma to the Groin Lymph Nodes
Melanoma and Skin Cancer Trials Limited 634
Testing effectiveness (Phase 2)UnknownNCT02036086
What this trial is testing

Study of Neo-adjuvant Use of Vemurafenib Plus Cobimetinib for BRAF Mutant Melanoma With Palpable Lymph Node Metastases

Who this might be right for
Melanoma
Sunnybrook Health Sciences Centre 24
Testing effectiveness (Phase 2)Looking for participantsNCT04598009
What this trial is testing

Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
University of California, San Francisco 25
Early research (Phase 1)UnknownNCT06556004
What this trial is testing

Phase 1 Study Using TRIMELVax for Stage IIIC / IV Melanoma Patients

Who this might be right for
Melanoma Stage IIIcMelanoma Stage IV
University of Chile 20
Large-scale testing (Phase 3)Active Not RecruitingNCT02339571
What this trial is testing

A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma

Who this might be right for
Stage III Cutaneous Melanoma AJCC v7Stage IV Cutaneous Melanoma AJCC v6 and v7
National Cancer Institute (NCI) 600
Testing effectiveness (Phase 2)Study completedNCT01258855
What this trial is testing

Aldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Metastatic MelanomaRecurrent MelanomaStage III Cutaneous Melanoma AJCC v7+4 more
National Cancer Institute (NCI) 84
Testing effectiveness (Phase 2)Study completedNCT00866177
What this trial is testing

MEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Recurrent MelanomaStage III Skin MelanomaStage IV Skin Melanoma
National Cancer Institute (NCI) 167
Large-scale testing (Phase 3)Ended earlyNCT05002569
What this trial is testing

Assess Adjuvant Immunotherapy With Nivolumab Plus Relatlimab Versus Nivolumab Alone After Complete Resection of Stage III-IV Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 1,093
Testing effectiveness (Phase 2)Study completedNCT00470470
What this trial is testing

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Acral Lentiginous Malignant MelanomaRecurrent MelanomaStage IIIA Melanoma+3 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)WithdrawnNCT03005639
What this trial is testing

ML29255 Neoadjuvant Vemurafenib and Cobimetinib Melanoma

Who this might be right for
Stage IIIB-C Melanoma
Inova Health Care Services
Next Page